Raymond James Financial’s AllianzIM U.S. Equity Buffer10 Dec ETF DECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.14M Sell
79,911
-786
-1% -$30.1K ﹤0.01% 3135
2026
Q1
$2.87M Sell
80,697
-4,816
-6% -$176K ﹤0.01% 3061
2025
Q4
$3.13M Buy
85,513
+11,453
+15% +$412K ﹤0.01% 2894
2025
Q3
$2.63M Buy
74,060
+18,758
+34% +$643K ﹤0.01% 2958
2025
Q2
$1.85M Sell
55,302
-4,400
-7% -$139K ﹤0.01% 3141
2025
Q1
$1.85M Buy
59,702
+3,178
+6% +$102K ﹤0.01% 3042
2024
Q4
$1.8M Buy
+56,524
New +$1.82M ﹤0.01% 3043

Other funds holding DECT

Raymond James Financial's DECT Position: Q2 2026 in Review

Raymond James Financial reduced its AllianzIM U.S. Equity Buffer10 Dec ETF (DECT) stake by 0.97% in Q2 2026, selling an estimated $30.1K and leaving 79,911 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3135.

Raymond James Financial first reported a position in DECT in Q4 2024 and has held it in 7 quarters since. 48 funds tracked by Wall St. Rank hold DECT as of Q2 2026.

  • Raymond James Financial held 79,911 shares of AllianzIM U.S. Equity Buffer10 Dec ETF worth $3.14M as of Q2 2026.
  • Raymond James Financial sold 786 AllianzIM U.S. Equity Buffer10 Dec ETF shares in Q2 2026, an estimated $30.1K.
  • AllianzIM U.S. Equity Buffer10 Dec ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3135 holding.
  • Raymond James Financial first reported a position in AllianzIM U.S. Equity Buffer10 Dec ETF in Q4 2024 and has held it in 7 quarters since.
  • 48 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Dec ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.